Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 1/2012

01.01.2012 | Original Paper

Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study

verfasst von: Chi-Hang Lee, Bee-Choo Tai, Gek-Hsiang Lim, Mark Y. Chan, Adrian F. Low, Kathryn C. Tan, Boon-Lock Chia, Huay-Cheem Tan

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Serum level of high density lipoprotein (HDL)-cholesterol is associated with risk of coronary artery disease. We correlated the serum level of cholesterol with coronary artery remodeling index of patients with coronary artery disease. A total of 120 patients with de novo lesions located in native coronary artery were studied. Remodeling index was based on intravascular ultrasound (IVUS) interrogation of the lesions using the static approach, and was defined as external elastic membrane (EEM) area at lesion/average EEM area at proximal and distal reference segments. The average remodeling index was 0.9 (SD: 0.2). The remodeling index was not associated with any of the demographic and coronary risk factors. Stable angina was associated with a low remodeling index. Remodeling index correlated with white blood cell count and HDL-cholesterol, but not with total cholesterol, LDL-cholesterol and triglyceride. In the multiple linear regression analysis, HDL-cholesterol and procedure indication were the only 2 significant predictors of remodeling index. An increase of 1 mg/dL of HDL-cholesterol resulted in a decrease of 0.003 (95% CI: 0.0001, 0.007; P = 0.046) in remodeling index, after adjusting for procedural indications. When stratified according to diabetic status, the negative correlation persisted in non-diabetic (P = 0.023), but not in diabetic, patients (P = 0.707). We found a negative correlation between HDL-cholesterol level and remodeling index. Diabetic status may have an influence on the observed relationship.
Literatur
1.
Zurück zum Zitat Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:1371–1375PubMedCrossRef Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:1371–1375PubMedCrossRef
2.
Zurück zum Zitat Hermiller JB, Tenaglia AN, Kisslo KB, Phillips HR, Bashore TM, Stack RS, Davidson CJ (1993) In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 71:665–668PubMedCrossRef Hermiller JB, Tenaglia AN, Kisslo KB, Phillips HR, Bashore TM, Stack RS, Davidson CJ (1993) In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 71:665–668PubMedCrossRef
3.
Zurück zum Zitat Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM (2000) Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101:598–603PubMed Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM (2000) Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101:598–603PubMed
4.
Zurück zum Zitat Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, Suzuki H, Ohnishi T, Kakuta Y, Nakano T, Yeung AC (2001) Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol 37:63–69PubMedCrossRef Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, Suzuki H, Ohnishi T, Kakuta Y, Nakano T, Yeung AC (2001) Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol 37:63–69PubMedCrossRef
5.
Zurück zum Zitat Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255–562PubMedCrossRef Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE (2008) Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52:255–562PubMedCrossRef
6.
Zurück zum Zitat Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE (2006) Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the reversal of atherosclerosis with aggressive lipid lowering therapy (REVERSAL) trial. Circulation 113:2826–2834PubMedCrossRef Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE (2006) Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the reversal of atherosclerosis with aggressive lipid lowering therapy (REVERSAL) trial. Circulation 113:2826–2834PubMedCrossRef
7.
Zurück zum Zitat Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med 62:707–714PubMedCrossRef Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med 62:707–714PubMedCrossRef
8.
Zurück zum Zitat Gordon DJ, Rifkind BM (1989) High-density lipoprotein—the clinical implications of recent studies. N Engl J Med 321:1311–1316PubMedCrossRef Gordon DJ, Rifkind BM (1989) High-density lipoprotein—the clinical implications of recent studies. N Engl J Med 321:1311–1316PubMedCrossRef
9.
Zurück zum Zitat Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC (2007) Treating to new targets investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301–1310PubMedCrossRef Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC (2007) Treating to new targets investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301–1310PubMedCrossRef
10.
Zurück zum Zitat Maccubbin D, Bays HE, Olsson AG, Elinoff V, Elis A, Mitchel Y, Sirah W, Betteridge A, Reyes R, Yu Q, Kuznetsova O, Sisk CM, Pasternak RC, Paolini JF (2008) Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract 62:1959–1970PubMedCrossRef Maccubbin D, Bays HE, Olsson AG, Elinoff V, Elis A, Mitchel Y, Sirah W, Betteridge A, Reyes R, Yu Q, Kuznetsova O, Sisk CM, Pasternak RC, Paolini JF (2008) Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Int J Clin Pract 62:1959–1970PubMedCrossRef
11.
Zurück zum Zitat Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A Report of the American College of Cardiology Task Force on clinical Expert Consensus Documents. J Am Coll Cardiol 37:1478–1492PubMedCrossRef Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A Report of the American College of Cardiology Task Force on clinical Expert Consensus Documents. J Am Coll Cardiol 37:1478–1492PubMedCrossRef
12.
Zurück zum Zitat Tauth J, Pinnow E, Sullebarger JT, Basta L, Gursoy S, Lindsay J Jr, Matar F (1997) Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 80:1352–1355PubMedCrossRef Tauth J, Pinnow E, Sullebarger JT, Basta L, Gursoy S, Lindsay J Jr, Matar F (1997) Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 80:1352–1355PubMedCrossRef
13.
Zurück zum Zitat Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB (1997) Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses: an intravascular ultrasound study. Circulation 95:1791–1798PubMed Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB (1997) Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses: an intravascular ultrasound study. Circulation 95:1791–1798PubMed
14.
Zurück zum Zitat Sabate’ M, Kay IP, de Feyter PJ, van Domburg RT, Deshpande NV, Ligthart JM, Gijzel AL, Wardeh AJ, Boersma E, Serruys PW (1999) Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol 94:135–140CrossRef Sabate’ M, Kay IP, de Feyter PJ, van Domburg RT, Deshpande NV, Ligthart JM, Gijzel AL, Wardeh AJ, Boersma E, Serruys PW (1999) Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol 94:135–140CrossRef
15.
Zurück zum Zitat Raffel OC, Merchant FM, Tearney GJ, Chia S, Gauthier DD, Pomerantsev E, Mizuno K, Bouma BE, Jang IK (2008) In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J 29:1721–1728PubMedCrossRef Raffel OC, Merchant FM, Tearney GJ, Chia S, Gauthier DD, Pomerantsev E, Mizuno K, Bouma BE, Jang IK (2008) In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J 29:1721–1728PubMedCrossRef
16.
Zurück zum Zitat Varnava AM, Mills PG, Davies MJ (2002) Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105:939–943PubMedCrossRef Varnava AM, Mills PG, Davies MJ (2002) Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105:939–943PubMedCrossRef
17.
Zurück zum Zitat Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, Arnesen E (2005) Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation 112:498–504PubMedCrossRef Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, Arnesen E (2005) Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation 112:498–504PubMedCrossRef
18.
Zurück zum Zitat Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A (2002) HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161:1–16PubMedCrossRef Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A (2002) HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161:1–16PubMedCrossRef
19.
Zurück zum Zitat Taylor AJ, Burke AP, Farb A, Yousefi P, Malcom GT, Smialek J, Virmani R (1999) Arterial remodeling in the left coronary system. J Am Coll Cardiol 34:760–767PubMedCrossRef Taylor AJ, Burke AP, Farb A, Yousefi P, Malcom GT, Smialek J, Virmani R (1999) Arterial remodeling in the left coronary system. J Am Coll Cardiol 34:760–767PubMedCrossRef
20.
Zurück zum Zitat Jiménez-Quevedo P, Sabaté M, Angiolillo D, Alfonso F, Hernández-Antolín R, Bañuelos C, Bernardo E, Ramirez C, Moreno R, Fernández C, Escaned J, Macaya C (2005) LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study. Eur Heart J 26:2307–2312PubMedCrossRef Jiménez-Quevedo P, Sabaté M, Angiolillo D, Alfonso F, Hernández-Antolín R, Bañuelos C, Bernardo E, Ramirez C, Moreno R, Fernández C, Escaned J, Macaya C (2005) LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study. Eur Heart J 26:2307–2312PubMedCrossRef
21.
Zurück zum Zitat Tan KC (2009) Reverse cholesterol transport in type 2 diabetes mellitus. Diabetes Obes Metab 11:534–543PubMedCrossRef Tan KC (2009) Reverse cholesterol transport in type 2 diabetes mellitus. Diabetes Obes Metab 11:534–543PubMedCrossRef
22.
Zurück zum Zitat Schartl M, Bocksch W (2006) How to assess coronary artery remodeling by intravascular ultrasound. Am Heart J 152:414–416PubMedCrossRef Schartl M, Bocksch W (2006) How to assess coronary artery remodeling by intravascular ultrasound. Am Heart J 152:414–416PubMedCrossRef
23.
Zurück zum Zitat Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Crowe T, Kapadia S, Nissen SE (2006) Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) trial. Am Heart J 152:544–550PubMedCrossRef Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Crowe T, Kapadia S, Nissen SE (2006) Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) trial. Am Heart J 152:544–550PubMedCrossRef
24.
Zurück zum Zitat Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, Hassan AH, Maehara A, Yeung AC, Pasterkamp G, Fitzgerald PJ, Yock PG (2005) Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 65:233–239PubMedCrossRef Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, Hassan AH, Maehara A, Yeung AC, Pasterkamp G, Fitzgerald PJ, Yock PG (2005) Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 65:233–239PubMedCrossRef
25.
Zurück zum Zitat Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC (2005) High-density lipoprotein function recent advances. J Am Coll Cardiol 46:1792–1798PubMedCrossRef Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC (2005) High-density lipoprotein function recent advances. J Am Coll Cardiol 46:1792–1798PubMedCrossRef
Metadaten
Titel
Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study
verfasst von
Chi-Hang Lee
Bee-Choo Tai
Gek-Hsiang Lim
Mark Y. Chan
Adrian F. Low
Kathryn C. Tan
Boon-Lock Chia
Huay-Cheem Tan
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 1/2012
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9777-y

Weitere Artikel der Ausgabe 1/2012

The International Journal of Cardiovascular Imaging 1/2012 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.